Previous 10 | Next 10 |
– Key MM-120 readouts in GAD (Phase 2b) and ADHD (Phase 2a) expected by end of 2023 – – MM-402 pre-clinical data in ASD model to be presented at ASCP 2023 Annual Meeting – – Strengthened leadership team with appointment of Mark R. Sullivan as...
Files Definitive Proxy Materials in Connection with June 15, 2023 Annual Meeting Board’s Nominees Possess Essential Pharmaceutical Industry, Capital Allocation and Corporate Governance Experience Needed to Drive Company’s Success at Pivotal Moment – With Two Key Clini...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or "MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Thursday, May 4, ...
Regulators in Oregon recently announced that they have approved a licensed testing lab for psilocybin, the first of its kind in the country. The Oregon Health Authority revealed that the license would be awarded to Rose City Labs. In a press release, Angie Allbee of Oregon Psilocybin Servic...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management tea...
Meaningful Change is Needed at MindMed After Years of Poor Performance FCM’s Candidates Have Decades of Relevant Industry Experience and are Laser Focused on Bringing MM-120 to Market FCM to Provide Detailed Operational Plan to Address MindMed’s Operational Challen...
Interest in psychedelics has increased these last few years, mainly as a result of numerous studies that have found that the substances possess a range of medical benefits. The decriminalization of psychedelics is also said to benefit society at large, with improvements being seen in public h...
Presents Highly Qualified Slate of Director Nominees, Including Five Incumbent Board Members and New Independent Candidate David W. Gryska Highlights Significant Positive Momentum to Advance R&D Pipeline and Enhance Shareholder Value Discloses FCM MM HOLDINGS’ Intent to...
2023-04-14 10:00:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ocugen (NASDAQ: OCGN ) stock is on the move Friday after the company revealed preliminary results from an ongoing clinical trial . The preliminary results come from the ...
2023-04-14 09:32:33 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mind Medicine (NASDAQ: MNMD ) stock is on the rise Friday after releasing positive results from a Phase 2 clinical trial. That clinical trial saw the company testing the e...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
2024-07-26 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...